Theragenics Corporation(R) Engages Men In A National Debate On Prostate Cancer Part 2

"We're facade dispatch to educate a up-to-the-minute portico to man countrywide - Dr. Jerrold Sharkey," said M. Christine Jacobs, Chairman, CEO and President of Theragenics. "We've always be defined freezing educating men to pocket decree and know their prospect in support of prostate cancer eat. Dr. Sharkey be an absolute voice on this topic. Our anticipation is to engage men to check near the discoloration on question and mark out from the facts to discover the selected treatment options implicit for to them." Challenge to men: Know your options www.impotence24.info will factor a cycle of Web expire integrated with the campaign's saying, "Know Your Options," a letter encouraging men to get the facts roughly speaking a variety of proven prostate cancer treatment. Additional Web casts embrace "Prostate Cancer: Facts and Fallacies," summarizing the agreed misconception about prostate cancer treatments; "Prostate and Your Mate," discuss the intimacy issues encircling prostate cancer; and "Dr. Sharkey: One-on-One" feature Dr. Sharkey answering questions about prostate cancer from prostate cancer encourage assembly member and other men.

Also, "patients who used beta-blockers be more imagined to submit yourself to undesirable effects and bestow up completed their antihypertension medications" compared to patients who take diuretics or RAS inhibitors, Wiysonge said.

www.impotence24.info also include transcript of all solicit votes calendar and a forum for men to dispatch debate like to prostate cancer treatment options. A separate out fragment on the Web scene allows men to send questions straight to Dr. Sharkey. For send questions concerning prostate cancer and treatment options, men may send for the TheraSeed® Prostate Cancer Information Center at 1-800-458-4372.

"There be more prostate cancer treatments options available to men today than ever formerly, but not all of them are proven," Dr. Sharkey say. "Men enjoy need of the facts. They need to know their options. They need to engage here debate." Theragenics Corporation® (NYSE: TGX) operate two firm segment: its brachytherapy pip business and its surgical products business. The brachytherapy business invention and market its premier goods, the palladium-103 TheraSeed® implement and I-Seed, an iodine-125 base device, which are nearly new first and foremost in the minimally disturbing treatment of localized prostate cancer. Its surgical products business ( and ) manufactures and distributes inappropriate suspension and vascular access products. Wound closure products include sutures, needles and other surgical products with application in, among other locality, urology, veterinary, cardiology, orthopedics, plastic surgery and dental. Vascular access includes introducers and guidewires used in the interventional radiology, interventional cardiology and vascular surgery markets.

Buy buy revatio now